Conocimiento de la tromboprofilaxis-COVID-19 en los profesionales sanitarios en España

  1. O. García Vallejo 1
  2. M. Frías Vargas 1
  3. I. Gil Gil 2
  4. N. Vázquez Gómez 3
  5. A. Piera Carbonell 4
  6. J. Peiró Morant 5
  1. 1 Centro de Salud Comillas, Madrid, España
  2. 2 Centro de Salud Vielha, Vielha, Lleida, España
  3. 3 Centro de Salud Auxiliar Moncófar, Moncófar, Castellón, España
  4. 4 Centro de Salud Luanco-Gozón, Luanco, Asturias, España
  5. 5 Centro de Salud Ponent, Mallorca, Islles Balears, España
Show affiliations +
Journal:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Year of publication: 2021

Issue: 6

Pages: 361-368

Type: Article

DOI: 10.1016/J.SEMERG.2021.01.002 DIALNET GOOGLE SCHOLAR

More publications in: Semergen: revista española de medicina de familia

Sustainable development goals

Abstract

Introduction Patients suffering from coronavirus infection have an increased risk of venous thromboembolic disease (VTE) associated with COVID-19, which confers a higher risk of mortality. For this reason, it is necessary to analyze the knowledge and the different actions in the management of thromboprophylaxis in work environments. Material and methods Observational, descriptive and cross-sectional study with data collection through a Google® form with 19 questions for professionals involved in the care of COVID-19. 414 surveys were received. The quantitative variables were represented with means and standard deviation and the qualitative variables with percentages and confidence intervals. Results 414 surveys analyzed. 58.2% were women. The most participatory age group was 56-65 years. 95.2% stated that COVID-19 patients had a higher risk of VTE and peripheral arterial microthrombosis. 93.6% considered that outpatient COVID-19 patients should receive thromboprophylaxis. 60.5% of the physicians did not know any protocol for the evaluation of thrombotic risk in these patients. Low molecular weight heparin was considered the main treatment for thromboprophylaxis. Conclusions The majority of doctors consider that COVID-19 patients have a higher risk of suffering VTE and peripheral arterial microthrombosis than the general population, however more than a third do not assess the thrombotic risk and a significant percentage claim not to know protocols to evaluate said risk. The survey highlights the training needs of our professionals in thromboprophylaxis so that our patients receive healthcare with the highest possible quality.

Bibliographic References

  • C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Yi. Hu, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan China Lancet, 395 (2020), pp. 497-506 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • N. Tang, H. Bai, X. Chen, J. Gong, D. Li, Z. Sun Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy J Thromb Haemost, 18 (2020), pp. 1094-1099, 10.1111/jth.14817 View PDFCrossRefView Record in ScopusGoogle Scholar
  • A. Serrano-Cumplido, P.B. Antón-Eguía Ortega, A. Ruíz García, V. Olmo Quintana, A. Segura Fragoso, A. Barquilla García, et al. COVID-19. La historia se repite y seguimos tropezando con la misma piedra Semergen, 46 (Supl) (2020), pp. S55-D61 Google Scholar
  • Z. Wu, J.M. McGoogan Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention JAMA., 323 (2020), pp. 1239-1242 View PDFCrossRefView Record in ScopusGoogle Scholar
  • D. Wichmann, J.P. Sperhake, M. Lütgehetmann, S. Steurer, C. Elder, A. Heinermann, et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19 Ann Intern Med, 173 (2020), pp. 268-277 View PDFCrossRefView Record in ScopusGoogle Scholar
  • S. Cui, S. Chen, X. Li, S. Liu, F. Wang Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia J Thromb Haemost, 18 (2020), pp. 1421-1424 View PDFCrossRefView Record in ScopusGoogle Scholar
  • F.A. Klok, M.J.H.A. Kruip, N.J.M. van der Meer, M.S. Arbous, Gommers DAMPJ, K.M. Kant, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Thromb Res, 191 (2020), pp. 145-147 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • N. Tang, D. Li, X. Wang, Z. Sun Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia J Thromb Haemost, 18 (2020), pp. 844-847 View PDFCrossRefView Record in ScopusGoogle Scholar
  • B. Bikdeli, M.V. Madhavan, D. Jimenez, T. Chuich, I. Dreyfus, E. Driggin, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up J Am Coll Cardiol, 75 (2020), pp. 2950-2973, 10.1016/j.jacc.2020.04.031 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • N. Tang, H. Bai, X. Chen, J. Gong, D. Li, Z. Sun Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy J Thromb Haemost, 18 (2020), pp. 1094-1099, 10.1111/jth.14817 View PDFCrossRefView Record in ScopusGoogle Scholar
  • S. Yin, M. Huang, D. Li, N. Tang Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 J Tromb Thrombolysis (2020), pp. 1-4, 10.1007/s11239-020-02105-8 View PDFCrossRefView Record in ScopusGoogle Scholar
  • R. López, J. Anguis, M. López, L. Giménez, P. Rodríguez, L. Suárez, et al. Escalas de riesgo de enfermedad tromboembólica venosa y su aplicabilidad en pacientes ambulatorios con sospecha de trombosis venosa profunda Actual Med, 104 (Supl) (2019), pp. 24-60Supl.-L View PDFView Record in ScopusGoogle Scholar
  • S. Barbar, F. Noventa, V. Rossetto, A. Ferrari, B. Brandolin, M. Perlati, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: The Padua Prediction Score J Thromb Haemost, 8 (2010), pp. 2450-2457 View PDFCrossRefView Record in ScopusGoogle Scholar
  • C. Kearon, J. Omelas, A. Blaivas, D. Jimenez, H. Bounameaux, M. Huisman, et al. Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report Chest, 149 (2016), pp. 315-352 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • [actualizado 21 Abr 2020; citado 27 Abr 2020] Disponible en: https://www.seth.es. Madrid: Sociedad Española de Trombosis y Hemostasia Disponible en:https://www.covid19.seth.es/wpcontent/uploads/2020/04/Recomendaciones-tromboprofilaxis-ytratamiento-antitrombotico-pacientes-COVID-19_2020-04-29.pdf Google Scholar
  • A. Piera Carbonell, A. García Lerín, O. García Vallejo, M. Frías Vargas, M.A. Cabrera Ferriols Trombosis y COVID-19: Atención Primaria clave en el abordaje interdisciplinar Semergen., 46 (2020), pp. 93-94, 10.1016/j.semerg.2020.06.002 ArticleDownload PDFView Record in ScopusGoogle Scholar
Data source: Dialnet